The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice
Open accessAbstract
Alcoholic liver disease (ALD) is characterized by steatosis and upregulation of proinflammatory cytokines, including IL-1β. IL-1β, type I IL-1 receptor (IL-1R1), and IL-1 receptor antagonist (IL-1Ra) are all important regulators of the IL-1 signaling complex, which plays a role in inflammation. Furthermore, IL-1β maturation is dependent on caspase-1 (Casp-1). Using IL-1Ra-treated mice as well as 3 mouse models deficient in regulators of IL-1β activation (Casp-1 and ASC) or signaling (IL-1R1), we found that IL-1β signaling is required for the development of alcohol-induced liver steatosis, inflammation, and injury. Increased IL-1β was due to upregulation of Casp-1 activity and inflammasome activation. The pathogenic role of IL-1 signaling in ALD was attributable to the activation of the inflammasome in BM-derived Kupffer cells. Importantly, in vivo intervention with a recombinant IL-1Ra blocked IL-1 signaling and markedly attenuated alcohol-induced liver inflammation, steatosis, and damage. Furthermore, physiological doses of IL-1β induced steatosis, increased the inflammatory and prosteatotic chemokine MCP-1 in hepatocytes, and augmented TLR4-dependent upregulation of inflammatory signaling in macrophages. In conclusion, we demonstrated that Casp-1-dependent upregulation of IL-1β and signaling mediated by IL-1R1 are crucial in ALD pathogenesis. Our findings suggest a potential role of IL-1R1 inhibition in the treatment of ALD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other macrophage-secreted cytokines that may promote HSC activation include PDGF, tumor necrosis factor alpha (TNFα), and interleukin 1 beta ( IL-1β) (65-69).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [66]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
Toll-like receptors and their crosstalk with other innate receptors in infection and immunity
Kawai, T., & Akira, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.006 · Cited by 3,658 · cited 1×
“Given the partial overlap of signaling pathways downstream of TLR4 and IL-1R1 (22), we hypothesized that IL-1β augments TLR4-dependent signaling in immune cells.”
BackgroundImmunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466 · cited 6×
“Although Casp-1 cleaves IL-1β, IL-18, and IL-33 (8), and IL-1R1 recognizes IL-1α, IL-1β, and IL-1Ra (16), our study provides several lines of evidence that IL-1β — not IL-18, IL-33, or IL-1α — is the primary cytokine that mediates the pathogenic effects of activated inflammasome in ALD.”
BackgroundInfluentialFitzgerald, M., Hayward, I. P., Thomas, A. C., Campbell, J. H., & CAMPBELL, G. R. (1995) · Cited by 2,552
O'Shea, R. S., Dasarathy, S., & McCullough, A. J. (2010) · Hepatology · doi:10.1002/hep.23258 · Cited by 1,077
Opal, S. M., Fisher, C. J., Dhainaut, J.-F. A., Vincent, J.-L., Brase, R., Lowry, S. F., Sadoff, J. C., Slotman, G. J., Levy, H., Balk, R. A., et al. (1997) · Critical Care Medicine · doi:10.1097/00003246-199707000-00010 · Cited by 865 · cited 2×
“In contrast to anti-TNF approaches, whose utility was compromised by infectious complications (1, 5), administration of IL-1Ra has demonstrated an excellent safety profile, and its use has not been associated with adverse reactions or superinfections with long-term treatment in patients with rheumatoid arthritis (38)…”
BackgroundToll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice
Miura, K., Kodama, Y., Inokuchi, S., Schnabl, B., Aoyama, T., Ohnishi, H., Olefsky, J. M., Brenner, D. A., & Seki, E. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.03.052 · Cited by 741 · cited 3×
“MCP-1 is a chemokine required for the pathogenesis of ALD (24) that, when present in high doses, induces lipid accumulation in hepatocytes (12).”
BackgroundSerum levels of cytokines in chronic liver diseases
Tilg, H., Wilmer, A., Vogel, W., Herold, M., Nölchen, B., Judmaier, G., & Huber, C. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91122-k · Cited by 739 · cited 1×
“IL-1β is a potent proinflammatory cytokine (6), whose levels are increased in patients with ALD (7).”
BackgroundAcetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome
Imaeda, A. B., Watanabe, A., Sohail, M. A., Mahmood, S., Mohamadnejad, M., Sutterwala, F. S., Flavell, R. A., & Mehal, W. Z. (2009) · Journal of Clinical Investigation · doi:10.1172/jci35958 · Cited by 607 · cited 1×
“Emerging data have provided evidence for the role of IL-1 signaling in acute and chronic liver injury of diverse origin, including acetaminophen-induced liver damage (11), nonalcoholic steatohepatitis (12), liver fibrosis (13), and immune-mediated liver injury (14).”
BackgroundIL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G
Lefrançais, E., Roga, S., Gautier, V., Gonzalez-de-Peredo, A., Monsarrat, B., Girard, J.-P., & Cayrol, C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115884109 · Cited by 594 · cited 16×
“First, alcohol administration in mice significantly increased IL-1β and IL-33, whereas levels of IL-1α and IL-18 remained unchanged.”
BackgroundInfluential
Research works printed but not linked: 3
- Thurman, 1998, Am J Physiol., 275, G605
- Mertens, 2009, Cochrane Database Syst Rev., CD005121
- Imaeda, 2009, J Clin Invest., 119, 305
Cited by
Molecular and cellular mechanisms of liver fibrosis and its regression
Kisseleva, T., & Brenner, D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00372-7 · Cited by 2,024
Resolving the fibrotic niche of human liver cirrhosis at single-cell level
Ramachandran, P., Dobie, R., Wilson-Kanamori, J. R., Dora, E. F., Henderson, B. E. P., Luu, N. T., Portman, J. R., Matchett, K. P., Brice, M., Marwick, J. A., et al. (2019) · Nature · doi:10.1038/s41586-019-1631-3 · Cited by 1,784
Liver Macrophages in Tissue Homeostasis and Disease
Krenkel, O., & Tacke, F. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.11 · Cited by 1,424
Seitz, H. K., Bataller, R., Cortez-Pinto, H., Gao, B., Gual, A., Lackner, C., Mathurin, P., Mueller, S., Szabo, G., & Tsukamoto, H. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0014-7 · Cited by 1,271
Mouse model of chronic and binge ethanol feeding (the NIAAA model)
Bertola, A., Mathews, S., Ki, S. H., Wang, H., & Gao, B. (2013) · Nature Protocols · doi:10.1038/nprot.2013.032 · Cited by 1,213
Metadata
- Authors
- Petrasek, J., Bala, S., Csak, T., Lippai, D., Kodys, K., Menashy, V., Barrieau, M., Min, S.-Y., Kurt-Jones, E. A., & Szabo, G.
- Affiliations
- University of Massachusetts Chan Medical School (US)
- ORCID
- Min, So-Yun
- Venue
- Journal of Clinical Investigation
- Published
- 2012-10-01
- Volume
- 122
- Issue
- 10
- Pages
- 3476-3489
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3461900
- OpenAlex
- W1975752601
- Cited by
- 735
- References
- 41
- Citations by year
- 2026: 24 · 2025: 55 · 2024: 61 · 2023: 70 · 2022: 63 · 2021: 37 · 2020: 55 · 2019: 50 · 2018: 66 · 2017: 58 · 2016: 55 · 2015: 55 · 2014: 49 · 2013: 33 · 2012: 4
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship@UMassChan (submittedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (R01AA017729, AA017729)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 32520, P30DK032520)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- interleukin-1 receptor antagonist, alcoholic steatohepatitis, alcoholic liver disease, IL-1β signaling, inflammasome, caspase-1, IL1R1, Kupffer cells, hepatic steatosis, liver inflammation, MCP-1, TLR4, macrophages, hepatocytes
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Ethanol, Animals, Carrier Proteins, Drug Evaluation, Preclinical, Fatty Liver, Alcoholic, Female, Kupffer Cells, Liver Cirrhosis, Mice, Inbred C57BL, Recombinant Proteins, Signal Transduction, Up-Regulation, Mice, Knockout, Chemokine CCL2, Caspase 1, Hepatocytes, Toll-Like Receptor 4, Mice, Receptors, Interleukin-1 Type I, Interleukin-1alpha, Interleukin-1beta, Interleukin 1 Receptor Antagonist Protein, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. https://app.cochat.ai/papers/10.1172/jci60777
- The paper
- Petrasek, J., Bala, S., Csak, T., Lippai, D., Kodys, K., Menashy, V., Barrieau, M., Min, S.-Y., Kurt-Jones, E. A., & Szabo, G. (2012). IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. Journal of Clinical Investigation. https://doi.org/10.1172/jci60777
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.